Table 3: Overall visual and surgical outcomes (n= 100).

Visual acuity, ECD, ECL and complications
Postoperative UCVA (n=99)
▪ 20/25 or better 27 (27.3%
▪ 20/30 to 20/60 55 (55.6%)
▪ <20/60 to 20/200 18 (18.2%)
▪ <20/200 09 (9.1%)
Postoperative BSCVA (n=99)
▪ 20/25 or better 57 (57.6%)
▪ 20/30 to 20/60 27 (31.4%)
▪ <20/60 to 20/200 10 (10.2%)
▪ <20/200 05 (5.1%)
Endothelial cell density – Donor
[Cells/sq mm; Mean ± SD (range)] 2891 ± 227 (2500 – 3717)
Endothelial cell density – after 3 months
[Cells/mm2; Mean ± SD (range)] 2123 ± 438 (976 – 3208)
Endothelial cell loss (ECL)
Percentage; Mean ± SD (range) 26.92 ± 13.40 (4.90% – 66.6%)
Complications - n; (%)
▪ Graft damaged during preparation 3 (3%)
▪ Graft damaged during unscrolling 2 (2%)
▪ Pupillary block 2 (2%)
▪ Detachment of DM graft
Total 1 (1%)
Partial central 2 (2%)
Partial peripheral 6 (6%)
▪ Iatrogenic primary donor failure 1 (1%)
▪ Secondary glaucoma 7 (7%)
▪ HSV recurrence 1 (1%)
▪ Infection/rejection Nil 19
▪ Comorbid other ocular conditions (19%)
Reoperations required:
▪ Rebubbling 4 (4%)
▪ Re DMEK 1 (1%)
UCVA: Uncorrected Visual Acuity; BSCVA: Best Spectacle Corrected Visual Acuity; DM: Descemet Membrane; HSV: Herpes Simplex Virus

Back to Article